Eagle Pharmaceuticals to Present at May Conferences

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that management will present at two conferences in May as follows:

Each presentation will be webcast live at the aforementioned times and URLs, and archived for 90 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160426006504/en/

Investor Relations for Eagle Pharmaceuticals, Inc:
In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Source: Eagle Pharmaceuticals, Inc.

You May Also Be Interested In

• BofA Securities Starts Houlihan Lokey (HLI) at Buy
• Corgi Insurance Welcomes Robert E. Barlow Jr. as EVP of Partnerships to Drive Expansion in Community Association and Property & Casualty Insurance
• Markets Reach New Highs as ELEKTROS Celebrates a 10.38% Friday Gain and Advances Its Long-Term Vision for a Next-Generation High-Speed EV Charging Infrastructure Network